Takeda Pharmaceutical Co., Ltd./ US8740602052 /
21/12/2018 00:00:00 | Var. - | Volume | Denaro- | Lettera- | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
16.5900USD | - | 7.86 mill. Fatturato: - |
-Quantità in denaro: - | -Quantità in lettera: - | 48.82 bill.USD | - | - |
GlobeNewswire
15:34
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
GlobeNewswire
15:30
New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsore...
GlobeNewswire
15:23
SEALSQ RISC-V Chips Adoption is Predicted to Get AI Boost Making it a Viable Competitor to Tradition...
GlobeNewswire
15:20
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
GlobeNewswire
15:15
Edible Garden Completes Phase Two of Packhouse Buildout at Company’s Flagship Belvidere NJ Facility
GlobeNewswire
15:00
Adams Diversified Equity Fund Announces Initiatives to Enhance Shareholder Value
GlobeNewswire
15:00
Golden Star Announces Cancellation of Business Combination Extraordinary General Meeting
GlobeNewswire
15:00
United Maritime Reports First Quarter 2024 Financial Results and Declares Quarterly Cash Dividend of...
GlobeNewswire
15:00
Pacific Software Inc. Acquires Scientifically Tested Medical Food Cocktail Focused on Memory Health
GlobeNewswire
15:00
Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation ...
GlobeNewswire
15:00
Tracy Robinson and Ghislain Houle to Address Bernstein’s 40th Annual Strategic Decisions Conference ...
GlobeNewswire
15:00
GCM Grosvenor to Present at the TD Financial Services & Fintech Summit on June 7, 2024
GlobeNewswire
14:45
Exela Technologies, Inc. to Host First Quarter 2024 Financial Results Conference Call
GlobeNewswire
14:45
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
GlobeNewswire
14:37
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework